High-intensity interval Nordic walking for Coronary Artery Disease

Phase-Based Progress Estimates

Effectiveness

Safety

University of Ottawa Heart Institute, Ottawa, Canada

Coronary Artery Disease+2 More

High-intensity interval Nordic walking - Behavioral

You have a chance of qualifying for this trial. We made sure your application will take less than 5 minutes.

Eligibility

18+

All Sexes

What conditions do you have?

Select

Eligibility

18+

All Sexes

What conditions do you have?

Select

Study Summary

Coronary revascularization, such as heart bypass surgery (CABG) and percutaneous coronary intervention (PCI [inserting a stent to open up blood vessels]) improve survival for people with coronary artery disease. Yet, many patients suffer from poor physical and mental health after coronary revascularization. Traditional cardiac rehabilitation involving moderate-to-vigorous intensity continuous training (MICT) improves physical and mental health. However, alternative exercise programs, such as high-intensity interval training (HIIT) and Nordic walking may provide superior benefits. Nordic walking is like Nordic skiing but uses specifically designed poles for walking. Nordic walking involved core, upper and lower body muscles, resulting in greater energy expenditure while reducing loading stress at the knee. To date, HIIT used in cardiac rehabilitation settings has focused on lower body (e.g., leg cycling). The investigators are not aware of HIIT protocols that target both upper and lower body at the same time. An exercise program that combines HIIT and Nordic walking (HIIT-NoW) may offer an alternative time-efficient whole-body exercise to improve physical and mental health. This study will test if HIIT-NoW can be an alternative exercise option to improve physical and mental health in patients with coronary artery disease.

Eligible Conditions

Coronary Artery Disease

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Coronary Artery Disease

AdVEGFXC1

standard care + moderate-intensity continuous exercise training

Study Objectives

7 Primary · 12 Secondary · Reporting Duration: Baseline to week 11 follow up

Week 11

Adherence

Adverse events

Blood pressure

Cardiorespiratory fitness

Compliance

Depression

Fat mass

Fat-free mass

Functional capacity

Gender

Heart Disease specific Quality of life (HeartQoL)

Physical activity levels

Quality of life (QoL)

Recruitment

Safety

Self-efficacy

Subjective exercise experiences

Subjective functinal capacity

Waist circumference

Trial Safety

Safety Progress

1 of 3

Other trials for Coronary Artery Disease

AdVEGFXC1

standard care + moderate-intensity continuous exercise training

Trial Design

2 Treatment Groups

Control

1 of 2

High-intensity interval Nordic walking

1 of 2

Active Control

Experimental Treatment

40 Total Participants · 2 Treatment Groups

Primary Treatment: High-intensity interval Nordic walking · No Placebo Group · N/A

High-intensity interval Nordic walking

Behavioral

Experimental Group · 1 Intervention: High-intensity interval Nordic walking · Intervention Types: Behavioral

Control

Behavioral

ActiveComparator Group · 1 Intervention: Standard cardiovascular rehabilitation · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline

Screening: ~3 weeks

Treatment: Varies

Reporting: baseline to week 11 follow up

Closest Location: University of Ottawa Heart Institute · Ottawa, Canada

2011First Recorded Clinical Trial

52 TrialsResearching Coronary Artery Disease

145 CompletedClinical Trials

Who is running the clinical trial?

Ottawa Heart Institute Research CorporationLead Sponsor

176 Previous Clinical Trials

87,948 Total Patients Enrolled

47 Trials studying Coronary Artery Disease

37,970 Patients Enrolled for Coronary Artery Disease

Jennifer L Reed, PhDPrincipal InvestigatorOttawa Heart Institute Research Corporation

6 Previous Clinical Trials

609 Total Patients Enrolled

1 Trials studying Coronary Artery Disease

135 Patients Enrolled for Coronary Artery Disease

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

You have coronary artery disease.

You are willing to come onsite for exercise sessions.

You are able to perform a cardiopulmonary exercise testing (CPET).

You are at least 40 years of age.

About The Reviewer

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References